Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00873210
What this trial is testing

Study In Patients With Kidney Cancer Treated With Sutent

Who this might be right for
Advanced or Metastatic Renal Cell CarcinomaRenal Cancer
Pfizer 121
Not applicableStudy completedNCT04941768
What this trial is testing

An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)

Who this might be right for
Carcinoma, Renal Cell
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 105
Early research (Phase 1)Looking for participantsNCT07623369
What this trial is testing

A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Huahui Health 299
Testing effectiveness (Phase 2)Looking for participantsNCT07469683
What this trial is testing

An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaNeoplasmsMalignant Neoplasms+1 more
Yonsei University 78
Testing effectiveness (Phase 2)UnknownNCT01274273
What this trial is testing

Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Aarhus 118
Testing effectiveness (Phase 2)UnknownNCT04387500
What this trial is testing

Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellFumarate Hydratase DeficiencyImmunotherapy
West China Hospital 41
Not applicableUnknownNCT04798963
What this trial is testing

The Evaluation of Functional Parenchymal Volume and Split Renal Function Before and After Partial Nephrectomy

Who this might be right for
Renal Cell Carcinoma
I.M. Sechenov First Moscow State Medical University 60
Early research (Phase 1)Looking for participantsNCT07688187
What this trial is testing

Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
PeptiDream Inc. 60
Not applicableStudy completedNCT02162732
What this trial is testing

Molecular-Guided Therapy for Childhood Cancer

Who this might be right for
NeuroblastomaMedulloblastomaGlioma+16 more
Giselle Sholler 186
Testing effectiveness (Phase 2)Study completedNCT00827359
What this trial is testing

Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaRenal Cancer
Beth Israel Deaconess Medical Center 25
Very early researchStudy completedNCT02626130
What this trial is testing

Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CancerStage IV Renal Cell Cancer AJCC v7
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT01158222
What this trial is testing

Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer
Case Comprehensive Cancer Center 37
Early research (Phase 1)UnknownNCT06049030
What this trial is testing

HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd. 190
Early research (Phase 1)Ended earlyNCT05229601
What this trial is testing

HFB301001 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Soft Tissue SarcomaRenal Cell CarcinomaUterine Carcinosarcoma+3 more
HiFiBiO Therapeutics 31
Not applicableLooking for participantsNCT04981119
What this trial is testing

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Who this might be right for
Solid Tumor, AdultColorectal CancerNon Small Cell Lung Cancer+14 more
A2 Biotherapeutics Inc. 500
Testing effectiveness (Phase 2)Study completedNCT00277017
What this trial is testing

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

Who this might be right for
KidneyCancer
New Mexico Cancer Research Alliance 15
Early research (Phase 1)Ended earlyNCT03905889
What this trial is testing

Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma Metastatic
Brown University 3
Not applicableNot Yet RecruitingNCT05725421
What this trial is testing

Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy

Who this might be right for
Renal Cell Carcinoma
Case Comprehensive Cancer Center 5
Not applicableLooking for participantsNCT07485114
What this trial is testing

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Non Small Cell Lung CancerHepatocellular Carcinoma+1 more
Daniel Keizman 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05863351
What this trial is testing

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

Who this might be right for
Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
ECOG-ACRIN Cancer Research Group 472
Next Page